Geode Capital Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Sell |
217,568
-187,387
| -46% | -$152K | ﹤0.01% | 3914 |
|
|
2025
Q1 | $311K | Buy |
404,955
+2,619
| +0.7% | +$2.01K | ﹤0.01% | 3708 |
|
|
2024
Q4 | $513K | Buy |
402,336
+10,620
| +3% | +$13.5K | ﹤0.01% | 3584 |
|
|
2024
Q3 | $811K | Buy |
391,716
+29,765
| +8% | +$61.6K | ﹤0.01% | 3427 |
|
|
2024
Q2 | $1.38M | Buy |
361,951
+319
| +0.1% | +$1.22K | ﹤0.01% | 3202 |
|
|
2024
Q1 | $1.71M | Buy |
361,632
+12,265
| +4% | +$58.1K | ﹤0.01% | 3175 |
|
|
2023
Q4 | $1.49M | Buy |
349,367
+18,267
| +6% | +$78K | ﹤0.01% | 3194 |
|
|
2023
Q3 | $1.02M | Buy |
331,100
+88,806
| +37% | +$274K | ﹤0.01% | 3307 |
|
|
2023
Q2 | $1.09M | Buy |
242,294
+96,390
| +66% | +$434K | ﹤0.01% | 3317 |
|
|
2023
Q1 | $832K | Buy |
145,904
+1,227
| +0.8% | +$6.99K | ﹤0.01% | 3427 |
|
|
2022
Q4 | $873K | Sell |
144,677
-8,414
| -5% | -$50.8K | ﹤0.01% | 3408 |
|
|
2022
Q3 | $1.01M | Buy |
153,091
+17,450
| +13% | +$115K | ﹤0.01% | 3380 |
|
|
2022
Q2 | $708K | Sell |
135,641
-71,935
| -35% | -$375K | ﹤0.01% | 3571 |
|
|
2022
Q1 | $1.43M | Sell |
207,576
-5,060
| -2% | -$34.9K | ﹤0.01% | 3434 |
|
|
2021
Q4 | $2.65M | Sell |
212,636
-36,536
| -15% | -$455K | ﹤0.01% | 3236 |
|
|
2021
Q3 | $7.79M | Buy |
249,172
+25,920
| +12% | +$810K | ﹤0.01% | 2646 |
|
|
2021
Q2 | $6.39M | Buy |
223,252
+24,061
| +12% | +$689K | ﹤0.01% | 2755 |
|
|
2021
Q1 | $8.63M | Buy |
199,191
+7,563
| +4% | +$328K | ﹤0.01% | 2453 |
|
|
2020
Q4 | $13.7M | Buy |
+191,628
| New | +$13.7M | ﹤0.01% | 1948 |
|